Acute coronary syndrome quality improvement in Kerala (ACS QUIK): Rationale and design for a cluster-randomized

Mark D Huffman1, Padinhare Purayil Mohanan2, Raji Devarajan3

  • 1Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.

Insights

This study introduces the ACS QUIK trial, a quality improvement intervention for acute coronary syndromes in India. It aims to enhance patient care and reduce major adverse cardiovascular events through a cluster-randomized stepped-wedge design.

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Trials

Background:

  • Ischemic heart disease is the leading cause of death in India, with a high burden of myocardial infarctions.
  • Previous studies in Kerala revealed suboptimal and inappropriate care for myocardial infarction patients.
  • Limitations in prior nonrandomized quality improvement studies necessitate robust trial designs.

Purpose of the Study:

  • To develop, implement, and evaluate a quality improvement intervention for acute coronary syndromes (ACS).
  • To improve process of care measures and clinical outcomes in ACS patients.
  • To assess the effectiveness of a cluster-randomized stepped-wedge design in quality improvement.

Main Methods:

  • The ACS QUIK trial is a cluster-randomized stepped-wedge clinical trial (NCT02256657).
  • Enrolling 15,750 participants with ACS across 63 hospitals in India.
  • Primary outcome: 30-day major adverse cardiovascular events (MACE). Secondary outcomes: quality of life and costs.

Main Results:

  • The trial aims to enroll a large cohort, with current participants predominantly male (76%) and diagnosed with ST-segment elevation myocardial infarction (63%).
  • The study is designed to measure the impact of the intervention on MACE and other key outcomes.
  • Detailed features and limitations of the stepped-wedge design are reported.

Conclusions:

  • The ACS QUIK trial addresses critical gaps in care for ischemic heart disease in India.
  • The stepped-wedge design offers a novel approach for evaluating quality improvement interventions in a real-world setting.
  • Findings will inform future strategies to improve cardiovascular care delivery and outcomes in India.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
358
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
353
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
427
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354